Climb Bio, Inc. · NASDAQ:CLYM
RA Capital Nexus Fund, L.P. exercised options for 70,000 Climb Bio, Inc. shares (Form 4)
Traded Sep 28, 2026 · Filed Sep 30, 2026
On Sep 28, 2026, RA Capital Nexus Fund, L.P. (Director) exercised options for 70,000 Climb Bio, Inc. shares at an average US$2.79 for US$195K, leaving 70,000 shares. Filed Sep 30, 2026 (Form 4).
- Options exercised
- 70,000 shares
- Price
- US$2.79 average (US$1.29 to US$7.89)
- Value
- US$195K
- Holding after
- 70,000 shares (held indirectly)
- Trading plan
- No
- Role
- Director
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Sep 28, 2026 | Common Stock | Option exercise | 10,000 | US$3.46 | 10,000 | Indirect |
| Sep 28, 2026 | Common Stock | Option exercise | 10,000 | US$3.00 | 20,000 | Indirect |
| Sep 28, 2026 | Common Stock | Option exercise | 10,000 | US$7.89 | 30,000 | Indirect |
| Sep 28, 2026 | Common Stock | Option exercise | 40,000 | US$1.29 | 70,000 | Indirect |